PPA
MCRB icon

Parametric Portfolio Associates’s Seres Therapeutics MCRB Stock Holding History

Parametric Portfolio Associates’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$190K Sell
1,333
-825
-38% -$127K ﹤0.01% 3455
2021
Q4 		$359K Sell
2,158
-1,352
-39% -$215K ﹤0.01% 3210
2021
Q3 		$489K Buy
3,510
+1,640
+88% +$321K ﹤0.01% 3119
2021
Q2 		$892K Buy
1,870
+158
+9% +$66.7K ﹤0.01% 2822
2021
Q1 		$705K Buy
1,712
+483
+39% +$222K ﹤0.01% 3320
2020
Q4 		$602K Sell
1,229
-2,113
-63% -$1.24M ﹤0.01% 3296
2020
Q3 		$1.89M Buy
3,342
+2,112
+172% +$702K ﹤0.01% 2539
2020
Q2 		$117K Buy
1,230
+104
+9% +$9.13K ﹤0.01% 3753
2020
Q1 		$80K Sell
1,126
-2,344
-68% -$157K ﹤0.01% 3765
2019
Q4 		$239K Buy
3,470
+48
+1% +$3.56K ﹤0.01% 3673
2019
Q3 		$274K Buy
3,422
+2,774
+428% +$183K ﹤0.01% 3581
2019
Q2 		$42K Buy
+648
New +$61.5K ﹤0.01% 3919
2017
Q4 		– Sell
-1,362
Closed -$437K – 3928
2017
Q3 		$437K Buy
1,362
+267
+24% +$73K ﹤0.01% 3492
2017
Q2 		$247K Buy
1,095
+28
+3% +$5.75K ﹤0.01% 3726
2017
Q1 		$240K Buy
1,067
+14
+1% +$2.84K ﹤0.01% 3529
2016
Q4 		$208K Buy
+1,053
New +$230K ﹤0.01% 3576
2016
Q3 		– Sell
-946
Closed -$550K – 3793
2016
Q2 		$550K Buy
946
+23
+2% +$13.5K ﹤0.01% 3132
2016
Q1 		$490K Buy
+923
New +$482K ﹤0.01% 3340

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Parametric Portfolio Associates's MCRB Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Seres Therapeutics (MCRB) stake by 38% in Q1 2022, selling an estimated $127K and leaving 1,333 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #3455.

Parametric Portfolio Associates first reported a position in MCRB in Q1 2016 and has held it in 18 quarters since. The position peaked at $1.89M in Q3 2020. 131 funds tracked by Wall St. Rank hold MCRB as of Q1 2022.

  • Parametric Portfolio Associates held 1,333 shares of Seres Therapeutics worth $190K as of Q1 2022.
  • Parametric Portfolio Associates sold 825 Seres Therapeutics shares in Q1 2022, an estimated $127K.
  • Seres Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3455 holding.
  • Parametric Portfolio Associates first reported a position in Seres Therapeutics in Q1 2016 and has held it in 18 quarters since.
  • Parametric Portfolio Associates's Seres Therapeutics position peaked at $1.89M in Q3 2020.
  • 131 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.